Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

60%

3 of 5 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 4

1(25.0%)

4Total

N/A(3)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT04803214Not ApplicableCompleted

ReActiv8 Stimulation Therapy vs Optimal Medical Management: A Randomized Evaluation

Role: lead

NCT04327817Phase 4Completed

Multifidus PET Scan Study

Role: collaborator

NCT02577354Not ApplicableCompleted

ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain

Role: lead

NCT03255200Completed

ReActiv8 Post Market Surveillance Registry

Role: lead

NCT01985230Not ApplicableCompleted

ReActiv8 for Chronic Low Back Pain (PMCF)

Role: lead

All 5 trials loaded